326030.KS · Korea · Healthcare
As of July 13, 2026 at 08:56 PM KST, SK바이오팜 (326030.KS) has a market cap of $4B (≈ ₩6.2T) — #290 worldwide on this unified board of 300 major Korean, US, and Japanese stocks, and #90 among Korea names. Down 1 spot from yesterday's baseline.
Compared with global #1 NVIDIA Corporation ($5.11T), that is 0.1% — it would take 1228.4× SK바이오팜 to match one NVIDIA Corporation. The gap to #289 코웨이 ($4B) right above is $187M. Right below at #291 is LG유플러스 ($4B).
Within the Healthcare sector it ranks #26 of 26; the sector leader is Eli Lilly and Company (global #13). The stock trades at $53.12, with roughly 78M shares outstanding (estimated).